CoDiagnostics (CODX)
(Delayed Data from NSDQ)
$1.17 USD
+0.06 (5.41%)
Updated Apr 29, 2024 03:59 PM ET
After-Market: $1.17 0.00 (0.00%) 5:14 PM ET
2-Buy of 5 2
F Value F Growth D Momentum F VGM
Income Statements
Fiscal Year end for CoDiagnostics, Inc falls in the month of December .
All items in Millions except EPS data.
12/31/23 | 12/31/22 | 12/31/21 | 12/31/20 | 12/31/19 | |
---|---|---|---|---|---|
Sales | 7 | 34 | 98 | 75 | 0 |
Cost Of Goods | 4 | 5 | 12 | 17 | 0 |
Gross Profit | 3 | 29 | 86 | 58 | 0 |
Selling & Adminstrative & Depr. & Amort Expenses | 45 | 56 | 40 | 16 | 6 |
Income After Depreciation & Amortization | -43 | -27 | 46 | 42 | -6 |
Non-Operating Income | 5 | 8 | 0 | 1 | 0 |
Interest Expense | 0 | 0 | 0 | 0 | 0 |
Pretax Income | -38 | -19 | 46 | 43 | -6 |
Income Taxes | -3 | -5 | 9 | 0 | 0 |
Minority Interest | 0 | 0 | 0 | 0 | 0 |
Investment Gains/Losses | 0 | 0 | 0 | 0 | 0 |
Other Income/Charges | 0 | 0 | 0 | 0 | 0 |
Income From Cont. Operations | -35 | -14 | 37 | 42 | -6 |
Extras & Discontinued Operations | 0 | 0 | 0 | 0 | 0 |
Net Income (GAAP) | -35 | -14 | 37 | 42 | -6 |
Depreciation Footnote | 12/31/23 | 12/31/22 | 12/31/21 | 12/31/20 | 12/31/19 |
---|---|---|---|---|---|
Income Before Depreciation & Amortization | -41 | -10 | 46 | 42 | -6 |
Depreciation & Amortization (Cash Flow) | 1 | 17 | 0 | 0 | 0 |
Income After Depreciation & Amortization | -43 | -27 | 46 | 42 | -6 |
Earnings Per Share Data | 12/31/23 | 12/31/22 | 12/31/21 | 12/31/20 | 12/31/19 |
---|---|---|---|---|---|
Average Shares | 29.35 | 31.48 | 29.90 | 28.00 | 16.76 |
Diluted EPS Before Non-Recurring Items | -1.20 | -0.26 | 1.23 | 1.52 | -0.36 |
Diluted Net EPS (GAAP) | -1.20 | -0.45 | 1.23 | 1.52 | -0.36 |
Fiscal Year end for CoDiagnostics, Inc falls in the month of December .
All items in Millions except EPS data.
3/31/24 | 12/31/23 | 9/30/23 | 6/30/23 | 3/31/23 | |
---|---|---|---|---|---|
Sales | NA | 3.56 | 2.46 | 0.20 | 0.60 |
Cost Of Goods | NA | 2.97 | 0.26 | 0.46 | 0.50 |
Gross Profit | NA | 0.59 | 2.20 | -0.26 | 0.10 |
SG&A, R&D, and Dept/Amort Expenses | 0.00 | 12.41 | 11.14 | 11.74 | 10.05 |
Income After SG&A, R&D, and Dept/Amort Expenses | 0.00 | -11.82 | -8.94 | -12.00 | -9.95 |
Non-Operating Income | NA | 0.98 | 0.84 | 0.84 | 1.94 |
Interest Expense | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Pretax Income | NA | -10.84 | -8.10 | -11.16 | -8.02 |
Income Taxes | NA | 3.83 | -2.11 | -2.24 | -2.26 |
Minority Interest | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Investment Gains/Losses | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Other Income/Charges | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Income From Cont. Operations | NA | -14.68 | -5.98 | -8.92 | -5.76 |
Extras & Discontinued Operations | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Net Income (GAAP) | NA | -14.68 | -5.98 | -8.92 | -5.76 |
Earnings Per Share Data | 3/31/24 | 12/31/23 | 9/30/23 | 6/30/23 | 3/31/23 |
---|---|---|---|---|---|
Average Shares | NA | 29.35 | 29.36 | 29.09 | 29.48 |
Diluted EPS Before Non-Recurring Items | NA | -0.50 | -0.20 | -0.31 | -0.20 |
Diluted Net EPS (GAAP) | NA | -0.49 | -0.20 | -0.31 | -0.20 |